Roanoke Asset Management Corp Johnson & Johnson Transaction History

Roanoke Asset Management Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$155.75 - $174.48 $6,230 - $6,979	-40 Reduced 0.94%	4,210 $656,000
Q2 2021 Jul 28, 2021	BUY	$159.48 - $171.07 $39,870 - $42,767	250 Added 6.25%	4,250 $700,000
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $17,547 - $19,228	125 Added 3.23%	4,000 $596,000
Q2 2020 Aug 05, 2020	BUY	$128.81 - $155.51 $18,033 - $21,771	140 Added 3.75%	3,875 $545,000
Q1 2020 May 13, 2020	BUY	$111.14 - $153.99 $27,785 - $38,497	250 Added 7.17%	3,735 $490,000
Q4 2019 Feb 05, 2020	BUY	$127.5 - $146.44 $27,412 - $31,484	215 Added 6.57%	3,485 $508,000
Q3 2019 Nov 01, 2019	SELL	$126.95 - $142.14 $64,744 - $72,491	-510 Reduced 13.49%	3,270 $423,000
Q4 2017 Jan 29, 2018	SELL	$131.22 - $143.62 $7,873 - $8,617	-60 Reduced 1.56%	3,780 $528,000
Q3 2017 Oct 20, 2017	BUY	$129.47 - $135.38 $497,164 - $519,859	3,840	3,840 $499,000

4,258

1.68B

16.1M

13.8M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $397B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Roanoke Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Roanoke Asset Management Corp with notifications on news.